ProKidney enters new $200M ATM equity facility with Jefferies, terminates prior agreement

PROKIDNEY CORP.

New Open Market Sale Agreement with Jefferies LLC allows sale of up to $200M of Class A common stock.
Jefferies will receive up to 3.0% compensation of gross proceeds from any sales under the agreement.
Prior $200M ATM agreement dated Jan 19, 2024 was mutually terminated effective July 14, 2025.
Company has no obligation to sell shares; sales may occur through various methods including Nasdaq.

item 1.01item 1.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.